| dbo:abstract |
Indisetron (INN; trade name Sinseron) is a drug used for prophylaxis of chemotherapy-induced nausea and vomiting. It was approved by Japan's Pharmaceuticals and Medical Devices Agency in 2004. Indisetron exerts its effects as a dual serotonin 5-HT3 and 5-HT4 receptor antagonist. (en) |
| dbo:alternativeName |
Sinseron (en) |
| dbo:casNumber |
141549-75-9 |
| dbo:chEBI |
135344 |
| dbo:chEMBL |
2104994 |
| dbo:fdaUniiCode |
89RBZ66NVC |
| dbo:kegg |
D02632 |
| dbo:pubchem |
178039 |
| dbo:thumbnail |
wiki-commons:Special:FilePath/Indisetron.svg?width=300 |
| dbo:wikiPageID |
69551495 (xsd:integer) |
| dbo:wikiPageLength |
3568 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID |
1061762507 (xsd:integer) |
| dbo:wikiPageWikiLink |
dbr:Chemotherapy-induced_nausea_and_vomiting dbr:Granisetron dbr:Receptor_antagonist dbr:Pharmaceuticals_and_Medical_Devices_Agency dbc:Indazoles dbr:5-HT3_receptor dbr:5-HT4_receptor dbc:Antiemetics dbr:Prophylaxis dbc:Amides dbr:Ondansetron dbr:International_Non-proprietary_Name |
| dbp:atcPrefix |
none (en) |
| dbp:c |
17 (xsd:integer) |
| dbp:casNumber |
141549 (xsd:integer) |
| dbp:chebi |
135344 (xsd:integer) |
| dbp:chembl |
2104994 (xsd:integer) |
| dbp:chemspiderid |
2302029 (xsd:integer) |
| dbp:h |
23 (xsd:integer) |
| dbp:iupacName |
N-[-3,9-Dimethyl-3,9-diazabicyclo[3.3.1]nonan-7-yl]-1H-indazole-3-carboxamide (en) |
| dbp:kegg |
D02632 (en) |
| dbp:legalStatus |
Rx in Japan (en) |
| dbp:n |
5 (xsd:integer) |
| dbp:o |
1 (xsd:integer) |
| dbp:pubchem |
178039 (xsd:integer) |
| dbp:smiles |
CN1C[C@H]2CCNCC3=NNC4=CC=CC=C43 (en) |
| dbp:stdinchi |
1 (xsd:integer) |
| dbp:stdinchikey |
MHNNVDILNTUWNS-YHWZYXNKSA-N (en) |
| dbp:synonyms |
N-3389 (en) |
| dbp:tradename |
Sinseron (en) |
| dbp:unii |
89 (xsd:integer) |
| dbp:wikiPageUsesTemplate |
dbt:Gastrointestinal-drug-stub dbt:Infobox_drug dbt:Reflist |
| dct:subject |
dbc:Indazoles dbc:Antiemetics dbc:Amides |
| rdf:type |
owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 dbo:Drug |
| rdfs:comment |
Indisetron (INN; trade name Sinseron) is a drug used for prophylaxis of chemotherapy-induced nausea and vomiting. It was approved by Japan's Pharmaceuticals and Medical Devices Agency in 2004. Indisetron exerts its effects as a dual serotonin 5-HT3 and 5-HT4 receptor antagonist. (en) |
| rdfs:label |
Indisetron (en) |
| owl:sameAs |
wikidata:Indisetron https://global.dbpedia.org/id/2YRLj |
| prov:wasDerivedFrom |
wikipedia-en:Indisetron?oldid=1061762507&ns=0 |
| foaf:depiction |
wiki-commons:Special:FilePath/Indisetron.svg |
| foaf:isPrimaryTopicOf |
wikipedia-en:Indisetron |
| is dbo:wikiPageRedirects of |
dbr:Sinseron dbr:Indisetron_hydrochloride |
| is dbo:wikiPageWikiLink of |
dbr:List_of_drugs:_Im–In dbr:Sinseron dbr:Indisetron_hydrochloride |
| is foaf:primaryTopic of |
wikipedia-en:Indisetron |
